{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:09:02Z","timestamp":1788818942142,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Psoriasis is a chronic inflammatory autoimmune disease with a prevalence of 2\u20133% in the western population. For the development of urgently needed new therapeutic options, standardizable and human-relevant disease models are essential. The transcription factor signal transducer and activator of transcription 3 (STAT3) plays a key role in the pro-inflammatory response of psoriatic keratinocytes. In this study, we established STAT3 overexpressing human keratinocytes and combined the cells with our epidermis and immune cell supplemented full-thickness skin model to generate a novel in vitro psoriasis model. In the full-thickness skin models STAT3 overexpression by its own was sufficient to induce enhanced expression of the psoriasis marker S100A7. Both epidermal and full-thickness skin models set up from STAT3 overexpressing keratinocytes showed a stronger psoriasis-like phenotype upon pro-inflammatory stimuli such as treatment with cytokines or integration of T cells compared to skin models set-up from the wild-type keratinocyte cell line. Thus, the STAT3 overexpression in keratinocytes induced a pre-psoriatic like phenotype in untreated skin models and enhanced the sensitivity of the skin models to psoriatic stimuli. This reflects the genetic susceptibility in psoriasis patients, which is responsible for the differences between non-lesional skin in patients and healthy skin. The novel STAT3 overexpressing in vitro skin model mimics many psoriatic hallmarks, is based on well-established immortalized primary keratinocytes and highly reproducible. Therefore, we expect it to be a well-suited psoriasis model for drug screening and validation approaches in a preclinical setting.<\/jats:p>","DOI":"10.3389\/fmed.2025.1539484","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T16:52:07Z","timestamp":1750870327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A standardizable human-based psoriasis skin model for drug development"],"prefix":"10.3389","volume":"12","author":[{"given":"Hanna","family":"Glasebach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Burger-Kentischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PTT.S327310","article-title":"Updated perspectives on keratinocytes and psoriasis: keratinocytes are more than innocent bystanders","volume":"12","author":"Ortiz-Lopez","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/exd.13525","article-title":"Past, present and future of in vitro 3D reconstructed inflammatory skin models to study psoriasis","volume":"27","author":"Niehues","year":"2018","journal-title":"Exp Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1038\/ncomms8001","article-title":"Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci","volume":"6","author":"Tsoi","year":"2015","journal-title":"Nat Commun"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.10-172288","article-title":"STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation","volume":"25","author":"Sestito","year":"2011","journal-title":"FASEB J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16874","article-title":"Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation","volume":"50","author":"Zhou","year":"2023","journal-title":"J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"754116","DOI":"10.3389\/fmed.2022.754116","article-title":"A scoping review on use of drugs targeting the JAK\/STAT pathway in psoriasis","volume":"9","author":"G\u00f3mez-Garc\u00eda","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"112378","DOI":"10.1016\/j.intimp.2024.112378","article-title":"Preclinical techniques for drug discovery in psoriasis","volume":"137","author":"Gujarathi","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jid.2017.10.013","article-title":"Research techniques made simple: murine models of human psoriasis","volume":"138","author":"Hawkes","year":"2018","journal-title":"J Invest Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.0022-202X.2004.23435.x","article-title":"The development and characterization of an in vitro model of psoriasis","volume":"123","author":"Barker","year":"2004","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jdermsci.2008.07.009","article-title":"Development of an in vitro psoriatic skin model by tissue engineering","volume":"53","author":"Jean","year":"2009","journal-title":"J Dermatol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071670","article-title":"Infiltration of T cells into a three-dimensional psoriatic skin model mimics pathological key features","volume":"20","author":"Lorthois","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2217\/rme-2016-0037","article-title":"Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis","volume":"11","author":"Pouliot-B\u00e9rub\u00e9","year":"2016","journal-title":"Regen Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/718725","article-title":"Keratinocytes under fire of Proinflammatory cytokines: Bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis","volume":"2012","author":"Bernard","year":"2012","journal-title":"J Allergy (Cairo)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41598-023-28822-7","article-title":"Induction of psoriasis-and atopic dermatitis-like phenotypes in 3D skin equivalents with a fibroblast-derived matrix","volume":"13","author":"Morgner","year":"2023","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1365-2133.2008.08769.x","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","article-title":"The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","volume":"178","author":"Sa","year":"2007","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.050541","article-title":"Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis","volume":"17","author":"Scheurer","year":"2024","journal-title":"Dis Model Mech"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2353\/ajpath.2008.080173","article-title":"Development and validation of human psoriatic skin equivalents","volume":"173","author":"Tjabringa","year":"2008","journal-title":"Am J Pathol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1038\/s41598-020-60275-0","article-title":"Recapitulating T cell infiltration in 3D psoriatic skin models for patient-specific drug testing","volume":"10","author":"Shin","year":"2020","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/jid.2013.417","article-title":"Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases","volume":"134","author":"van den Bogaard","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref34","volume-title":"Methods Mol Biol","author":"Ubago-Rodr\u00edguez","year":"2024"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/978-1-4939-6515-1_25","article-title":"Immune cell-supplemented human skin model for studying fungal infections","volume":"1508","author":"K\u00fchbacher","year":"","journal-title":"Methods Mol Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/infdis\/jix153","article-title":"Central role for dermal fibroblasts in skin model protection against Candida albicans","volume":"215","author":"K\u00fchbacher","year":"","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1242\/jcs.072520","article-title":"The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3","volume":"124","author":"Vogt","year":"2011","journal-title":"J Cell Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.0303-6987.2004.0220.x","article-title":"K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis","volume":"31","author":"Bhawan","year":"2004","journal-title":"J Cutan Pathol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1479-5876-8-104","article-title":"Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation","volume":"8","author":"Li","year":"2010","journal-title":"J Transl Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e12808","DOI":"10.1111\/sji.12808","article-title":"Determination of cell expansion and surface molecule expression on anti-CD3\/28 expanded CD4(+) T cells","volume":"90","author":"Thitilertdecha","year":"2019","journal-title":"Scand J Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0022-1759(03)00010-3","article-title":"T cell stimulation and expansion using anti-CD3\/CD28 beads","volume":"275","author":"Trickett","year":"2003","journal-title":"J Immunol Methods"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jid.2021.09.012","article-title":"IL-6R\/signal transducer and activator of transcription 3 signaling in keratinocytes rather than in T cells induces psoriasis-like dermatitis in mice","volume":"142","author":"Ravipati","year":"2022","journal-title":"J Invest Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4331\/wjbc.v5.i2.231","article-title":"Regulation and function of signal transducer and activator of transcription 3","volume":"5","author":"Qi","year":"2014","journal-title":"World J Biol Chem"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e101937","DOI":"10.1371\/journal.pone.0101937","article-title":"Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1\u03b1, TNF\u03b1 and oncostatin M","volume":"9","author":"Rabeony","year":"2014","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/apm.13221","article-title":"Role of IL-22 in homeostasis and diseases of the skin","volume":"130","author":"Lopez","year":"2022","journal-title":"APMIS"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1159\/000524119","article-title":"Looking at Interleukin-22 from a new dermatological perspective: from epidermal homeostasis to its role in chronic skin diseases","volume":"238","author":"Prignano","year":"2022","journal-title":"Dermatology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1016\/j.cub.2020.01.004","article-title":"Epidermal structure and differentiation","volume":"30","author":"Moreci","year":"2020","journal-title":"Curr Biol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/jid.2009.247","article-title":"Skin-resident T cells: the ups and downs of on site immunity","volume":"130","author":"Clark","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122526","article-title":"The genetic basis of psoriasis","volume":"18","author":"Capon","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.mehy.2008.06.049","article-title":"The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1","volume":"72","author":"Cabrijan","year":"2009","journal-title":"Med Hypotheses"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1684\/ejd.2021.4015","article-title":"Psoriasis is a disease of the entire skin: non-lesional skin displays a prepsoriasis phenotype","volume":"31","author":"Nosbaum","year":"2021","journal-title":"Eur J Dermatol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1038\/s41598-019-47774-5","article-title":"Comprehensive proteomic analysis reveals intermediate stage of non-Lesional psoriatic skin and points out the importance of proteins outside this trend","volume":"9","author":"Sz\u00e9l","year":"2019","journal-title":"Sci Rep"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/1535370217710637","article-title":"In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research","volume":"242","author":"Desmet","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1539484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:05:37Z","timestamp":1751558737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1539484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":58,"alternative-id":["10.3389\/fmed.2025.1539484"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1539484","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1539484"}}